Mukia maderaspatana — Hermetica Encyclopedia
Herbs (Global Traditional) · Ayurveda

Mukia maderaspatana

Moderate Evidencebotanical

Hermetica Superfood Encyclopedia

The Short Answer

Mukia maderaspatana is an Ayurvedic climbing herb containing bioactive triterpenoids and flavonoids that demonstrates blood sugar regulation properties through insulin potentiation mechanisms. The plant shows gastric protective effects by modulating inflammatory pathways including TNF-α suppression.

PubMed Studies
0
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerbs (Global Traditional)
GroupAyurveda
Evidence LevelModerate
Primary KeywordMukia maderaspatana benefits
Synergy Pairings3
Mukia maderaspatana close-up macro showing natural texture and detail — rich in antioxidant, anti-inflammatory, hepatoprotective
Mukia maderaspatana — botanical close-up

Health Benefits

Origin & History

Mukia maderaspatana growing in India — natural habitat
Natural habitat

Mukia maderaspatana is a climbing herb from the Cucurbitaceae family native to India, also known as Melothria maderaspatana. The whole plant, leaves, or fruit peels are dried and extracted using methanol, ethanol, or water to produce phenolic-rich preparations containing compounds like quercetin and phloroglucinol.

Mukia maderaspatana has been used extensively in Indian folk medicine for decades, with over 60% of the global population relying on such traditional remedies. Historical applications documented since at least 1996 include treatment of diabetes, gastric ulcers, hypertension, liver disorders, inflammation, arthritis, asthma, and stress.Traditional Medicine

Scientific Research

No human clinical trials have been conducted on Mukia maderaspatana; all evidence comes from preclinical animal and laboratory studies. Key animal research includes antidiabetic effects in rat liver models (PMID: 24251899), gastroprotective activity against indomethacin-induced ulcers (PMID: 25471339), and neuroprotective effects in D-galactose-induced anxiety/depression models (PMID: 37415861).

Preparation & Dosage

Mukia maderaspatana ground into fine powder — pairs with Mukia maderaspatana pairs effectively with Gymnema sylvestre, where gymnemic acids and Mukia's cucurbitacins act on complementary glycemic pathways — Gymnema suppresses intestinal glucose absorption while Mukia's constituents inhibit hepatic gluconeogenesis, producing additive blood sugar regulation. Ashwagandha (Withania somnifera) complements its serotonergic and stress-modulating activity
Traditional preparation

No human dosage data exists. Animal studies used methanol extracts at 0.25-0.5 mg/ml in vitro, and fruit peel powder at 125-2000 mg/kg/day orally in rats, with effects typically seen at 500-2000 mg/kg. Consult a healthcare provider before starting any new supplement.

Nutritional Profile

Mukia maderaspatana (Cucurbitaceae family) contains limited macronutrient data, but bioactive phytochemical characterization reveals: flavonoids including vitexin, isovitexin, and luteolin glycosides; cucurbitacin-type triterpenoids; saponins (estimated 2–4% dry weight); alkaloids in trace concentrations; and phenolic acids including caffeic and chlorogenic acid derivatives. Tannin content is approximately 1.8–3.2% dry weight. The herb contains beta-sitosterol and stigmasterol as primary phytosterols. Mineral content includes moderate potassium, calcium, and magnesium with trace iron and zinc, though precise concentrations lack standardized published values. Crude fiber content is estimated at 8–12% in whole plant material. The aerial parts and leaves contain the highest concentration of bioactive cucurbitacins and flavonoids. Bioavailability of its flavonoid glycosides is enhanced in the presence of gut microbiota-mediated deglycosylation, and lipid co-administration may improve absorption of its fat-soluble triterpenoids.

How It Works

Mechanism of Action

Mukia maderaspatana's triterpenoid compounds enhance insulin sensitivity and inhibit hepatic gluconeogenesis pathways, contributing to glucose homeostasis. The plant's flavonoid constituents suppress pro-inflammatory cytokines like TNF-α while reducing lipid peroxidation markers such as malondialdehyde. These dual mechanisms support both metabolic and gastric protective functions through antioxidant and anti-inflammatory pathways.

Clinical Evidence

Current evidence for Mukia maderaspatana is limited to animal studies and preliminary research. Rat liver studies demonstrated an 89% reduction in gluconeogenesis markers, indicating potential blood sugar benefits, though human clinical trials are lacking. Gastric protection studies in animal models showed significant reductions in inflammatory markers TNF-α and malondialdehyde levels. The absence of human clinical data limits the strength of evidence for therapeutic applications.

Safety & Interactions

Safety data for Mukia maderaspatana is extremely limited with no established human dosage guidelines or toxicity studies. The herb may potentially interact with diabetes medications due to its glucose-lowering properties, requiring medical supervision for diabetic patients. Pregnancy and lactation safety has not been established, making use inadvisable during these periods. Individuals with gastric conditions should consult healthcare providers before use despite potential protective effects.

Synergy Stack

Hermetica Formulation Heuristic

Frequently Asked Questions

What compounds in Mukia maderaspatana lower blood sugar?
Triterpenoids and flavonoids are the primary bioactive compounds responsible for blood sugar effects. These compounds work by enhancing insulin sensitivity and inhibiting hepatic gluconeogenesis, achieving up to 89% reduction in glucose production in animal studies.
How much Mukia maderaspatana should I take daily?
No standardized human dosage exists for Mukia maderaspatana as clinical trials have not been conducted. Animal studies used extract concentrations, but these cannot be directly translated to safe human doses without proper clinical research.
Can Mukia maderaspatana replace diabetes medication?
Mukia maderaspatana should never replace prescribed diabetes medications as evidence is limited to animal studies only. The herb may potentially enhance blood sugar control as a complementary approach under medical supervision, but human efficacy and safety data are lacking.
Does Mukia maderaspatana help with stomach ulcers?
Animal studies suggest gastric protective effects through TNF-α suppression and reduced malondialdehyde levels, indicating anti-inflammatory properties. However, human studies are needed to confirm ulcer prevention or healing benefits, and medical treatment should not be delayed for gastric conditions.
What are the side effects of Mukia maderaspatana?
Side effects are unknown due to lack of human safety studies and clinical trials. Potential hypoglycemia risk exists for diabetic patients due to glucose-lowering properties. Pregnant women and individuals on medications should avoid use until safety data becomes available.
Is Mukia maderaspatana safe during pregnancy and breastfeeding?
There is insufficient clinical evidence on the safety of Mukia maderaspatana during pregnancy and breastfeeding, as most research has been conducted in animal models only. Due to its traditional use as a digestive aid and lack of human safety data, pregnant and nursing women should consult a healthcare provider before supplementation. The ingredient has not been formally evaluated for fetal toxicity or presence in breast milk.
Does Mukia maderaspatana interact with diabetes or psychiatric medications?
Because Mukia maderaspatana shows preliminary evidence for blood sugar reduction and serotonin modulation in animal studies, it may theoretically interact with antidiabetic medications (increasing hypoglycemia risk) or serotonergic psychiatric drugs (SSRIs, SNRIs). No human clinical trials have formally assessed these interactions, so concurrent use with prescription medications requires medical supervision. Anyone taking diabetes or mood-regulating medications should inform their healthcare provider before starting this supplement.
How strong is the scientific evidence for Mukia maderaspatana's health claims?
Current evidence for Mukia maderaspatana is limited to animal studies and traditional use reports; no large-scale randomized controlled trials in humans have been published. The most robust preliminary data shows an 89% reduction in liver glucose production in rat models, but this does not guarantee equivalent effects in humans. Most claims regarding stress, mood, and memory support remain at the preclinical stage and require human clinical validation before definitive health recommendations can be made.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.